No Data
No Data
No Data
No Data
No Data
Regulus Files to Sell 62.5M Shares of Common Stock for Holders
Seeking AlphaApr 10 05:06
Buy Rating Reaffirmed for Regulus Therapeutics Amid Promising Drug Development Milestones
TipRanksMar 25 18:26
Regulus Therapeutics Inc (RGLS) Reports Year-End Earnings, Highlights Key Clinical Advancements
Yahoo FinanceMar 23 17:33
Regulus Therapeutics Q4 EPS $(0.40) Misses $(0.39) Estimate
Regulus Therapeutics (NASDAQ:RGLS) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.39) by 2.56 percent. This is unchanged from the same period last ye
BenzingaMar 22 04:08
Regulus Therapeutics 4Q Loss $8.06M >RGLS
Regulus Therapeutics 4Q Loss $8.06M >RGLS
Dow JonesMar 22 04:05
Press Release: Regulus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Updates
Regulus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Updates PR Newswire SAN DIEGO, March 21, 2024 Positive topline data from the second cohort of patients in
Dow JonesMar 22 04:05
No Data
No Data